Abbott India Future Growth

Future criteria checks 3/6

Abbott India is forecast to grow earnings and revenue by 13.2% and 11.1% per annum respectively. EPS is expected to grow by 13.5% per annum. Return on equity is forecast to be 32.7% in 3 years.

Key information

13.2%

Earnings growth rate

13.5%

EPS growth rate

Pharmaceuticals earnings growth	18.7%
Revenue growth rate	11.1%
Future return on equity	32.7%
Analyst coverage	Good
Last updated	19 Apr 2024

Recent future growth updates

Recent updates

Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?

Feb 23

Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price

Jan 07

Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's

Jul 15

Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00

Jul 01

Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00

May 22

With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case

Apr 14

How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?

Mar 24

The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It

Mar 03

Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Feb 04

How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?

Jan 14

Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why

Dec 24

Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years

Dec 03

Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?

Nov 12

Is Abbott India Limited's (NSE:ABBOTINDIA) Recent Performance Tethered To Its Attractive Financial Prospects?

Oct 25

Do Institutions Own Abbott India Limited (NSE:ABBOTINDIA) Shares?

Oct 04

Why Abbott India Limited (NSE:ABBOTINDIA) Should Be In Your Dividend Portfolio

Sep 13

Abbott India Limited (NSE:ABBOTINDIA) Looks Interesting, And It's About To Pay A Dividend

Aug 23

Is Abbott India's (NSE:ABBOTINDIA) 295% Share Price Increase Well Justified?

Aug 17

Earnings Tell The Story For Abbott India Limited (NSE:ABBOTINDIA)

Jul 27

What You Need To Know About Abbott India Limited's (NSE:ABBOTINDIA) Investor Composition

Jul 06

Earnings and Revenue Growth Forecasts

NSEI:ABBOTINDIA - Analysts future estimates and past financials data (INR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2026	73,376	15,342	14,007	N/A	6
3/31/2025	65,791	13,448	11,625	N/A	6
3/31/2024	58,912	11,878	10,469	N/A	6
12/31/2023	57,534	11,456	N/A	N/A	N/A
9/30/2023	56,384	10,814	11,593	12,068	N/A
6/30/2023	55,236	10,340	N/A	N/A	N/A
3/31/2023	53,487	9,494	8,593	8,934	N/A
12/31/2022	52,654	9,294	N/A	N/A	N/A
9/30/2022	51,632	8,818	8,174	8,511	N/A
6/30/2022	50,058	8,086	N/A	N/A	N/A
3/31/2022	49,133	7,987	9,036	9,477	N/A
12/31/2021	47,598	7,398	N/A	N/A	N/A
9/30/2021	46,308	7,177	8,938	9,416	N/A
6/30/2021	44,636	7,061	N/A	N/A	N/A
3/31/2021	43,100	6,907	7,034	7,267	N/A
12/31/2020	41,757	6,492	N/A	N/A	N/A
9/30/2020	41,586	6,587	5,965	6,099	N/A
6/30/2020	41,585	6,563	N/A	N/A	N/A
3/31/2020	40,931	5,929	6,104	6,261	N/A
12/31/2019	40,383	5,952	N/A	N/A	N/A
9/30/2019	39,077	5,255	3,595	3,719	N/A
6/30/2019	38,326	4,849	N/A	N/A	N/A
3/31/2019	36,786	4,503	4,866	4,991	N/A
12/31/2018	35,606	4,372	N/A	N/A	N/A
9/30/2018	34,941	4,355	N/A	N/A	N/A
6/30/2018	34,460	4,354	N/A	N/A	N/A
3/31/2018	32,985	4,012	1,799	1,527	N/A
12/31/2017	32,242	3,432	N/A	N/A	N/A
9/30/2017	30,893	3,134	N/A	N/A	N/A
6/30/2017	28,794	2,509	N/A	N/A	N/A
3/31/2017	29,026	2,766	N/A	3,072	N/A
12/31/2016	28,959	2,980	N/A	N/A	N/A
9/30/2016	28,097	2,802	N/A	N/A	N/A
6/30/2016	27,293	2,663	N/A	N/A	N/A
3/31/2016	26,145	2,553	N/A	2,487	N/A
12/31/2015	25,380	2,504	N/A	N/A	N/A
9/30/2015	24,504	2,445	N/A	N/A	N/A
6/30/2015	23,950	2,466	N/A	N/A	N/A
3/31/2015	22,893	2,290	N/A	2,148	N/A
12/31/2014	22,008	2,176	N/A	N/A	N/A
9/30/2014	21,103	2,065	N/A	N/A	N/A
6/30/2014	19,776	1,880	N/A	N/A	N/A
3/31/2014	18,694	1,668	N/A	1,243	N/A
12/31/2013	17,527	1,601	N/A	N/A	N/A
9/30/2013	17,580	1,273	N/A	N/A	N/A
6/30/2013	17,196	1,495	N/A	N/A	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ABBOTINDIA's forecast earnings growth (13.2% per year) is above the savings rate (6.7%).

Earnings vs Market: ABBOTINDIA's earnings (13.2% per year) are forecast to grow slower than the Indian market (17.5% per year).

High Growth Earnings: ABBOTINDIA's earnings are forecast to grow, but not significantly.

Revenue vs Market: ABBOTINDIA's revenue (11.1% per year) is forecast to grow faster than the Indian market (10% per year).

High Growth Revenue: ABBOTINDIA's revenue (11.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ABBOTINDIA's Return on Equity is forecast to be high in 3 years time (32.7%)

Abbott India Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Price target increased by 10% to ₹27,242

Price target increased to ₹19,998

Recent updates

Abbott India Limited Appoints Murari Ranganathan as Commercial Director

Less than half of directors are independent

Price target increased by 10% to ₹27,242

Abbott India Limited Announces Resignation of Sandeep Reddy - Commercial Director - Women's Health, Metabolics and International Business, with Effect from June 5, 2024

Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?

Abbott India Limited to Report Q3, 2024 Results on Feb 01, 2024

Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price

Abbott India Limited Announces Resignation of Vivek V Kamath as Managing Director, Effective from March 18, 2024

Second quarter 2024 earnings released: EPS: ₹147 (vs ₹125 in 2Q 2023)

Abbott India Limited to Report Q2, 2024 Results on Nov 09, 2023

Abbott India Limited Approves Appointment of Sangeeta Shetty as Company Secretary, Effective September 14, 2023

New major risk - Earnings quality

Abbott India Limited to Report Q1, 2024 Results on Aug 09, 2023

Abbott India Limited Appoints Ms Richa Tripathi as Associate Director, Effective August 3, 2023

Full year 2023 earnings released: EPS: ₹447 (vs ₹376 in FY 2022)

Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's

Upcoming dividend of ₹325 per share at 1.4% yield

Less than half of directors are independent

Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00

Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00

Full year 2023 earnings released: EPS: ₹447 (vs ₹376 in FY 2022)

Abbott India Limited, Annual General Meeting, Aug 09, 2023

With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case

Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?

Third quarter 2023 earnings released: EPS: ₹116 (vs ₹93.74 in 3Q 2022)

Abbott India Limited to Report Q3, 2023 Results on Feb 10, 2023

Is Now The Time To Put Abbott India (NSE:ABBOTINDIA) On Your Watchlist?

Less than half of directors are independent

Abbott India Limited to Report Q2, 2023 Results on Nov 14, 2022

Abbott India Limited Approves Final Dividend for the Financial Year Ended March 31, 2022

Abbott India Limited to Report Q1, 2023 Results on Aug 10, 2022

Upcoming dividend of ₹275 per share

Full year 2022 earnings released: EPS: ₹376 (vs ₹325 in FY 2021)

Abbott India Limited, Annual General Meeting, Aug 10, 2022

Full year 2022 earnings released: EPS: ₹376 (vs ₹325 in FY 2021)

Abbott India Limited Recommends Special Dividend for the Year Ended March 31, 2022

Abbott India Limited to Report Q4, 2022 Results on May 17, 2022

Less than half of directors are independent

We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease

Less than half of directors are independent

Abbott India Limited Appoints Vivek V Kamath as Additional Director

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Abbott India Limited to Report Q3, 2022 Results on Feb 09, 2022

Here's Why We Think Abbott India (NSE:ABBOTINDIA) Is Well Worth Watching

A Look At The Intrinsic Value Of Abbott India Limited (NSE:ABBOTINDIA)

Price target increased to ₹19,998

Second quarter 2022 earnings released: EPS ₹90.51 (vs ₹85.05 in 2Q 2021)

Do Abbott India's (NSE:ABBOTINDIA) Earnings Warrant Your Attention?

Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet

Should You Be Adding Abbott India (NSE:ABBOTINDIA) To Your Watchlist Today?

Upcoming dividend of ₹275 per share

Full year 2021 earnings released: EPS ₹325 (vs ₹279 in FY 2020)

Additional Non-Executive Director has left the company

Abbott India Limited Recommends the Payment of Final Dividend for the Year Ended March 31, 2021, Payable on and After August 3, 2021

Full year 2021 earnings released: EPS ₹325 (vs ₹279 in FY 2020)

How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?

The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It

Third quarter 2021 earnings released: EPS ₹83.36 (vs ₹87.85 in 3Q 2020)

Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

New 90-day low: ₹14,222

Abbott India Limited to Report Q3, 2021 Results on Feb 09, 2021

How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?

New 90-day low: ₹15,002

Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why

Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years

New 90-day low: ₹15,096

Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?

Second quarter 2021 earnings released: EPS ₹85.05

New 90-day low: ₹15,327

Is Abbott India Limited's (NSE:ABBOTINDIA) Recent Performance Tethered To Its Attractive Financial Prospects?

Do Institutions Own Abbott India Limited (NSE:ABBOTINDIA) Shares?

Abbott India Limited Appoints Karen Peterson as Additional and Non-Executive Director

Abbott India Limited(BSE:500488) dropped from S&P Global BMI Index